Canine invasive transitional cell carcinoma cell lines: In vitro tools to complement a relevant animal model of invasive urinary bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 3, 2009, Pages 284-292

  Dhawan, Deepika ^a   Ramos Vara, José A ^a   Stewart, Jane C ^a   Zheng, Rong ^a   Knapp, Deborah W ^a,b,c  

^a PURDUE UNIVERSITY   (United States)

^b Purdue University   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Animal models; Canine; Cell lines; Invasive urinary bladder cancer; Transitional cell carcinoma

Indexed keywords

CYCLOOXYGENASE 2; CYTOKERATIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CARCINOMA CELL; CONTROLLED STUDY; DOG; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CADHERINS; CARCINOMA, TRANSITIONAL CELL; CELL PROLIFERATION; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOGS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROGNOSIS; RETINOBLASTOMA PROTEIN; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 65349099911     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.02.015     Document Type: Article

References (20)

1. Cancer Facts and Figures (2007), American Cancer Society
2. Knapp D.W. Animal models: Naturally Occurring Canine Urinary Bladder Cancer. In: Lerner S.P., Schoenberg M.P., and Sternberg C.N. (Eds). Textbook of Bladder Cancer (2006), Taylor and Francis, Oxon, UK 171-175
3. Knapp D.W., Glickman N.W., DeNicola D.B., et al. Naturally occurring canine transitional cell carcinoma of the urinary bladder, a relevant model of human invasive bladder cancer-a prospective study. Urol Oncol 5 (2000) 47-59
4. Knapp D.W., Chan T.C., Kuczek T., et al. Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells. Am J Vet Res 56 (1995) 801-805
5. Mohammed S.I., Dhawan D., Abraham S., et al. Cyclo-oxygenase inhibitors in urinary bladder cancer: In vitro and in vivo effects. Mol Cancer Ther 5 (2006) 329-336
6. Hoang A.T., Cohen K.J., Barrett J.F., et al. Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 91 (1994) 6875-6879
7. Paoloni M., and Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 8 (2008) 147-156
8. Rosai J. Surgical techniques in surgical pathology. In: Rosai J. (Ed). Rosai and Ackerman's Surgical Pathology, 9th ed (2004), Mosby, Edinburgh, UK 37-91
9. Broers J.L., Carney D.N., de Ley L., et al. Differential expression of intermediate filament proteins distinguishes classic form variant small-cell lung cancer cell lines. Proc Natl Acad Sci 82 (1985) 4409-4413
10. Broers J.L., Rot M.K., Oostendorp T., et al. Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines. J Cell Sci 91 (1988) 91-108
11. Franke W.W., Schmid E., Winter S., et al. Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates. Exp Cell Res 123 (1979) 25-46
12. Virtanen I., Lehto V.P., Lehtonen E., et al. Expression of intermediate filaments in cultured cells. J Cell Sci 50 (1981) 45-63
13. Summerhayes I.C., Cheng Y.E., Sun T.T., et al. Expression of keratin and vimentin intermediate filaments in rabbit bladder epithelial cells at different stages of benzo[a]pyrene-induced neoplastic progression. J Cell Biol 90 (1981) 63-69
14. Baumgart E., Cohen M.S., Silva Neto B., et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 13 (2007) 1685-1694
15. Lee J.M., Dedhar S., Kalluri R., et al. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172 (2006) 973-981
16. Sánchez-Carbayo M., and Cordon-Cardo C. Applications of array technology: Identification of molecular targets in bladder cancer. Br J Cancer 89 (2003) 2172-2177
17. Cordon-Cardo C., Zhang Z.F., Dalbagni G., et al. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 57 (1997) 1217-1221
18. Mohammed S.I., Knapp D.W., Bostwick D.G., et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 59 (1999) 5647-5650
19. Sanchez-Carbayo M., Socci N.D., Charytonowicz E., et al. Molecular profiling of bladder cancer using cDNA microarrays: Defining histogenesis and biological phenotypes. Cancer Res 62 (2002) 6973-6980
20. Nakopoulou L., Vourlakou C., Zervas A., et al. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Human Pathol 29 (1998) 146-154